GSK will become the first partner of the new Imperial-led Fleming Initiative, which aims to tackle antimicrobial resistance globally. Global biopharma company GSK will become the first founding partner of the Fleming Initiative, an innovative and collaborative new approach led by Imperial College London and Imperial College Healthcare NHS Trust and to tackle antimicrobial resistance (AMR) around the world. A £45m pledge…
Ben KempMay 22, 2024